tiprankstipranks
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market
ARTV
Artiva Biotherapeutics, Inc.
RESEARCH TOOLSreports
Want to see ARTV full AI Analyst Report?

Artiva Biotherapeutics, Inc. (ARTV) Stock News & Sentiment

468 Followers
Artiva Biotherapeutics Announces Major Executive Leadership Transitions
Premium
Company Announcements
Artiva Biotherapeutics Announces Major Executive Leadership Transitions
5d ago
8K
ARTV
Tyler Van Buren Reiterates Buy on Artiva, Citing Strong AlloNK RA Efficacy and Funded Path to Registrational Trial
Premium
Ratings
Tyler Van Buren Reiterates Buy on Artiva, Citing Strong AlloNK RA Efficacy and Funded Path to Registrational Trial
13d ago
ARTV
Artiva Biotherapeutics Announces $300 Million Equity Offering
Premium
Company Announcements
Artiva Biotherapeutics Announces $300 Million Equity Offering
15d ago
8K
ARTV
Artiva Highlights AlloNK RA Data and Phase 3 Alignment
Premium
Company Announcements
Artiva Highlights AlloNK RA Data and Phase 3 Alignment
16d ago
8K
ARTV
Artiva: Sufficient Cash Runway to 2027 Supports Buy Rating Ahead of Key 2026 RA Efficacy Readouts
Premium
Ratings
Artiva: Sufficient Cash Runway to 2027 Supports Buy Rating Ahead of Key 2026 RA Efficacy Readouts
2M ago
ARTV
Artiva: De-Risking RA Opportunity With AlloNK and Fast-Track Path Supports Buy Rating
Premium
Ratings
Artiva: De-Risking RA Opportunity With AlloNK and Fast-Track Path Supports Buy Rating
2M ago
ARTV
Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer
Premium
Company Announcements
Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer
3M ago
8K
ARTV
More ARTV News >

ARTV News on the Web

Major Insider Move Signals Big Confidence in Artiva Biotherapeutics
TipRanks News
Neutral
Artiva Biotherapeutics price target raised to $41 from $18 at Needham
TipRanks News
Bullish
Needham Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)
TipRanks News
Bullish
Artiva Biotherapeutics price target raised to $40 from $23 at Wedbush
TipRanks News
Bullish
Cantor Fitzgerald Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)
TipRanks News
Bullish
Tyler Van Buren Reiterates Buy on Artiva, Citing Strong AlloNK RA Efficacy and Funded Path to Registrational Trial
TipRanks News
Bullish
Artiva Biotherapeutics Announces $300 Million Equity Offering
TipRanks News
Neutral
Artiva Biotherapeutics price target raised to $35 from $15 at H.C. Wainwright
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
ARTV
Sector Average
Media Buzz
This Week3 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ARTV’s Media Buzz Sentiment?
3 articles about ARTV were published this week. In an average week, 3.25 articles are published.
    What is ARTV’s weekly average amount of articles?
    In an average week, 3.25 articles about ARTV are published.
      What is ARTV’s News Sentiment?
      100% of articles about ARTV were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week